Clinical Trial Update: Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection

View source ↗

Summary

A completed clinical trial evaluating two PET tracers, 68Ga-CTR-FAPI and 18F-FDG, for cancer detection. The study compares imaging performance in tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-CTR-FAPI (CTR-FAPI)

Snippet

Sponsor: Lanzhou University Second Hospital | Conditions: Tumors, PET / CT | Status: COMPLETED